CDC25A and chronic myelogenous leukemia, BCR-ABL1 positive: This study uniquely integrates bioinformatic prediction with in vitro expression validation to propose a disease-specific miR-122-5p/CDC25A regulatory axis potentially involved in CML pathogenesis.